Expression of Sox2 and Oct4 and their clinical significance in human non-small-cell lung cancer.
about
Advances in Lung Stem Cells and Lung Cancer Stem CellsOver-expression of deubiquitinating enzyme USP14 in lung adenocarcinoma promotes proliferation through the accumulation of β-cateninExpression of OCT4A: the first step to the next stage of urothelial bladder cancer progressionEmbryonic stem cell markers Sox-2 and OCT4 expression and their correlation with WNT signal pathway in cervical squamous cell carcinoma.Knockdown of OCT4 suppresses the growth and invasion of pancreatic cancer cells through inhibition of the AKT pathwayThe prognostic value of SOX2 expression in non-small cell lung cancer: a meta-analysisIdentification of biological properties of intralymphatic tumor related to the development of lymph node metastasis in lung adenocarcinomaStem cells, progenitors & regenerative medicine: A retrospection.Anterior gradient protein 2 expression in high grade head and neck squamous cell carcinoma correlated with cancer stem cell and epithelial mesenchymal transition.Clinical significance of OCT4 and SOX2 protein expression in cervical cancer.The role of SOX-2 on the survival of patients with non-small cell lung cancerThe role of Sox genes in lung morphogenesis and cancer.The prognostic value of whole blood SOX2, NANOG and OCT4 mRNA expression in advanced small-cell lung cancer.Stemness and inducing differentiation of small cell lung cancer NCI-H446 cells.Clinicopathological and prognostic significance of Oct-4 expression in patients with non-small cell lung cancer: a systematic review and meta-analysis.Epigenetic alterations leading to TMPRSS4 promoter hypomethylation and protein overexpression predict poor prognosis in squamous lung cancer patientsAssociation of SOX2 and Nestin DNA amplification and protein expression with clinical features and overall survival in non-small cell lung cancer: A systematic review and meta-analysis.The multiple roles for Sox2 in stem cell maintenance and tumorigenesis.SOX2 and p63 colocalize at genetic loci in squamous cell carcinomas.Structure and function of BCRP, a broad specificity transporter of xenobiotics and endobiotics.Knockdown of OCT4 may sensitize NSCLC cells to cisplatin.Overexpression of the non-coding SOX2OT variants 4 and 7 in lung tumors suggests an oncogenic role in lung cancer.Cancer Stem Cells: Dynamic Entities in an Ever-Evolving Paradigm.SOX2 regulates apoptosis through MAP4K4-survivin signaling pathway in human lung cancer cells.Distinctive expression pattern of OCT4 variants in different types of breast cancer.Overexpression of OCT4 is associated with gefitinib resistance in non-small cell lung cancer.SOX15 and other SOX family members are important mediators of tumorigenesis in multiple cancer types.SOX2 expression is associated with FGFR fusion genes and predicts favorable outcome in lung squamous cell carcinomas.Correlation of Cancer Stem-Cell Markers OCT4, SOX2, and NANOG with Clinicopathological Features and Prognosis in Operative Patients with Rectal Cancer.Correlation of cancer stem cell markers and immune cell markers in resected non-small cell lung cancer.Stemness-Related Markers in Cancer.RKIP and peroxiredoxin 2 expression predicts the proliferative potential of gastric cancer stem cells.3D modeling of cancer stem cell niche.Quantification of serum SOX2 DNA with FQ-PCR potentially provides a diagnostic biomarker for lung cancer.OCT4, SOX2, and NAN OG positive expression correlates with poor differentiation, advanced disease stages, and worse overall survival in HER2 + breast cancer patients
P2860
Q26781688-C0842B3B-810E-48AD-99D2-D64513DFAC08Q28385613-D9D873D3-194B-4082-92D2-301CD154E47FQ28396049-620388CB-6BA6-497E-BF9C-FE786616C8A2Q33802858-04032B0F-8D13-4F54-8AB2-1230E754F017Q34000656-6C50BFB4-1A8F-468A-9D27-72B1A34E62CAQ34976982-56A8E5E6-7866-4F08-8E80-172A2161CA4CQ35078103-973D1410-A0E7-4363-B744-27A3EF2DD28DQ35564636-21895EFE-CDA4-46D3-BFE8-39EA2FA69EC8Q35832228-11839876-98A0-4AB2-82BC-40D4C76FB40AQ35878793-71183C5D-92C5-4D96-8F6A-DE10E681118DQ35909244-A598258A-D149-4D7E-9192-662542AE8B9EQ36538306-C015B3E6-F550-4CBE-B4D6-D23AD82A2D39Q36857674-77D5792B-886B-49ED-A761-1B95F3998B70Q36907105-0D14F50F-7DA6-45A4-B7EC-6F7161B85E3EQ37121374-1589BC65-21F2-4608-A050-484D1BCA5C69Q37225665-24A00E4D-FD04-4D9E-9F2B-68F97FF1F81CQ37376323-1DA20CE2-43A9-491A-A258-3B78B8B382A0Q37411246-AE868901-A536-498A-A382-DC2986555AC1Q37680006-6C7CF811-B933-482E-AA5E-D6D9000B2BDFQ38207943-CDE0307C-E10B-4786-B0D7-643A343B2A73Q38731917-24B44A5B-DCD3-489A-9C13-504057C48FE2Q38796631-4BA8374B-6088-4A87-83CE-5392798FD745Q38829440-9C57BA64-9DAF-4693-8A11-07B2A3AA0B04Q39063028-039861AF-4E59-47DA-AFF1-74A32BB6FA22Q39215105-9740889B-F6ED-410D-B450-D475A6731D15Q42158350-606C9F2E-0BE2-4E3A-9ABC-3AD9984E13FDQ43083428-8FDFAC87-B108-47C9-BD7B-EA2A15BC903CQ43201485-3E4DAB2A-8AF4-474D-A388-9D8428696BDCQ47101770-2087B41A-AAE0-440A-B623-EDCFDAB9EA90Q47130408-2C8AFE3E-C605-4A25-B6FB-290693037953Q47176774-4F58FA51-9FC8-4574-BE45-C3E518C11181Q49447218-797CE7DF-8416-4BB8-AB6C-EB5D494DD646Q49621285-93D237C6-01C3-42E2-BD3F-A5E705718BB5Q54239435-B31D2090-3755-4F3F-81E4-BD2B8C5279B6Q59135024-AC8DDDB3-D8B7-4595-8B7F-A3674DABFEBC
P2860
Expression of Sox2 and Oct4 and their clinical significance in human non-small-cell lung cancer.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Expression of Sox2 and Oct4 an ...... an non-small-cell lung cancer.
@ast
Expression of Sox2 and Oct4 an ...... an non-small-cell lung cancer.
@en
type
label
Expression of Sox2 and Oct4 an ...... an non-small-cell lung cancer.
@ast
Expression of Sox2 and Oct4 an ...... an non-small-cell lung cancer.
@en
prefLabel
Expression of Sox2 and Oct4 an ...... an non-small-cell lung cancer.
@ast
Expression of Sox2 and Oct4 an ...... an non-small-cell lung cancer.
@en
P2093
P2860
P356
P1476
Expression of Sox2 and Oct4 an ...... an non-small-cell lung cancer.
@en
P2093
Aftab Ahmad
Encheng Li
Jinguang Wang
P2860
P304
P356
10.3390/IJMS13067663
P407
P577
2012-06-21T00:00:00Z